Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance

Environmental Health Perspectives
R BascomD L Swift

Abstract

Nasal mucociliary clearance (NMC) is a biomarker of nasal mucosal function. Tobacco smokers have been shown to have abnormal NMC, but the acute effect of environmental tobacco smoke (ETS) on nonsmokers is unknown. This study evaluated acute tobacco smoke-induced alterations in NMC in 12 healthy adults. Subjects were studied on 2 days, separated by at least 1 week. Subjects underwent a 60-min controlled exposure at rest to air or sidestream tobacco smoke (SS) (15 ppm CO) in a controlled environmental chamber. One hour after the exposure, 99mTc-sulfur colloid was aerosolized throughout the nasal passage and counts were measured with a scintillation detector. Six out of 12 subjects showed more rapid clearance after smoke exposure than after air exposure, and 3/12 had rapid clearance on both days. However, substantial decreases in clearance occurred in 3/12 subjects, all of whom had a history of ETS rhinitis. In two subjects, more than 90% of the tracer remained 1 hr after tracer administration (2 hr after smoke exposure). Understanding the basis for biologic variability in the acute effect of tobacco smoke on NMC may advance our understanding of pathogenesis of chronic effects of ETS.

References

Mar 1, 1977·Archives of Environmental Health·J SebbenR J Shephard
May 1, 1992·Archives of Environmental Health·S R WillesR Bascom
Jun 1, 1991·The American Review of Respiratory Disease·R BascomD Proud
Jun 1, 1990·Journal of Applied Physiology·L B WongD B Yeates
Jan 1, 1973·Archives of Internal Medicine·R E AlbertD Bohning
Jan 1, 1974·Archives of Environmental Health·I B AndersenD F Proctor
Jan 1, 1984·Journal of Toxicology and Environmental Health·M Lippmann, R B Schlesinger
Jun 1, 1984·Environmental Health Perspectives·R F PhalenR T Drew
Dec 24, 1982·European Journal of Pharmacology·J M LundbergC R Martling
Apr 5, 1995·JAMA : the Journal of the American Medical Association·S A Glantz, W W Parmley

❮ Previous
Next ❯

Citations

Feb 27, 2004·Tobacco Control·J M Samet
Jun 10, 2011·Lung India : Official Organ of Indian Chest Society·Johnson PriscillaA S Subhashini
Mar 5, 2003·Free Radical Biology & Medicine·Celia J ReedEdward A Lock
Oct 27, 2009·Inhalation Toxicology·Tuvia HadarJacob Shvero
Jul 30, 2011·Expert Opinion on Pharmacotherapy·Elisa VillaGiorgio Walter Canonica
May 29, 2007·COPD·Jung-Soo Kim, Bruce K Rubin
Dec 24, 2011·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jinny E ChangDonald D Stevenson
Apr 17, 2016·Immunology and Allergy Clinics of North America·Dennis Shusterman
May 1, 2001·Human & Experimental Toxicology·E Nelson
Mar 3, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Mehmet HabesogluCagatay Oysu
Feb 2, 2012·International Forum of Allergy & Rhinology·Tshipukane Dieudonné NyembueJean Marie Kayembe
Feb 14, 2018·International Forum of Allergy & Rhinology·Sarah K WiseMark Zacharek
Sep 22, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Andreas D FlourisYiannis Koutedakis
Nov 22, 2012·Pediatric Pulmonology·Sedat OktemRefika Ersu
Oct 20, 2018·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Núria Piqué, Barbara De Servi
Dec 24, 2010·Current Opinion in Pulmonary Medicine·Andreas D Flouris, Yiannis Koutedakis
Nov 15, 2001·The Journal of Allergy and Clinical Immunology·J BousquetUNKNOWN World Health Organization

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.